LB Pharmaceuticals Inc. announced the appointments of Ellen Rose as Senior Vice President, Corporate Affairs and Lindsay Beaupre as Senior Vice President, People and Culture. Ellen Rose is a strategic communications executive with deep expertise spanning corporate affairs and investor relations, including external and internal communications, media, patient advocacy, and government affairs. Prior to joining LB Pharmaceuticals, Ellen Rose served as Senior Vice President, Communications and Investor Relations at Lyell Immunopharma where she was a member of the executive leadership team.
She held a similar role as Senior Vice President Communications and Chief of Staff at Prothena Corporation plc. Earlier in her career Ellen Rose held positions of increasing responsibility within Johnson & Johnson. Ellen Rose holds a B.A. in International Relations from Stanford University.
Lindsay Beaupre is a strategic and results-driven People and Culture executive with an extensive track record in the biotech and financial services sectors, driving organizational effectiveness, leadership capability, and cultural clarity. She partners closely with executive teams to build high-performing organizations during periods of growth and change. Most recently Lindsay Beaupre was the Chief Administrative Officer at Lyndra Therapeutics, where she led enterprise-wide people and operational initiatives.
Earlier in her career she held senior people leadership roles at prominent biotech companies such as Vertex Pharmaceuticals and Immunogen, as well as State Street and Fidelity Investments. Lindsay Beaupre holds a B.S. degree from the University of Massachusetts, Amherst.
